Literature DB >> 10492158

Intraesophageal pH monitoring during acid infusion in patients with systemic sclerosis.

F Carola1, P A Bianchi, G Basilisco.   

Abstract

Incidental clinical observations suggest that buffering substances may accumulate in the distal esophagus of patients with systemic sclerosis. The aim of our study was to assess if the buffering capacity of the intraesophageal milieu is increased in patients with systemic sclerosis and if this effect can be correlated to some pathophysiological aspects of the disease. We recorded intraesophageal pH before and during a 10-min intraesophageal infusion of acid (HCl 0.01 N, 1 ml/min), as well as esophageal motility and clearance function, in 16 patients with systemic sclerosis and 10 healthy subjects. Esophageal buffering capacity expressed as the area under the curve of intraesophageal pH during acid infusion was significantly higher in the patients than in the controls, and this variable was directly correlated with esophageal clearing time. In conclusion, esophageal buffering capacity is increased in patients with systemic sclerosis and is possibly the consequence of the accumulation of buffering substances in the distal esophagus.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10492158     DOI: 10.1023/a:1026656220075

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  17 in total

1.  APERISTALSIS OF THE ESOPHAGUS IN PATIENTS WITH CONNECTIVE-TISSUE DISORDERS AND RAYNAUD'S PHENOMENON.

Authors:  M B STEVENS; P HOOKMAN; C I SIEGEL; J R ESTERLY; L E SHULMAN; T R HENDRIX
Journal:  N Engl J Med       Date:  1964-06-04       Impact factor: 91.245

2.  Scleroderma (systemic sclerosis): classification, subsets and pathogenesis.

Authors:  E C LeRoy; C Black; R Fleischmajer; S Jablonska; T Krieg; T A Medsger; N Rowell; F Wollheim
Journal:  J Rheumatol       Date:  1988-02       Impact factor: 4.666

3.  Oesophageal acid clearance in patients with systemic sclerosis: effect of body position.

Authors:  G Basilisco; F Carola; M Vanoli; P Bianchi; R Barbera
Journal:  Eur J Gastroenterol Hepatol       Date:  1996-03       Impact factor: 2.566

4.  Gastroesophageal reflux in esophageal scleroderma: diagnosis and implications.

Authors:  M B Orringer; L Dabich; C J Zarafonetis; H Sloan
Journal:  Ann Thorac Surg       Date:  1976-08       Impact factor: 4.330

5.  Effects of acid and bile salts on the rabbit esophageal mucosa.

Authors:  J W Harmon; L F Johnson; C L Maydonovitch
Journal:  Dig Dis Sci       Date:  1981-01       Impact factor: 3.199

6.  Acid neutralizing capacity of human saliva.

Authors:  J F Helm; W J Dodds; W J Hogan; K H Soergel; M S Egide; C M Wood
Journal:  Gastroenterology       Date:  1982-07       Impact factor: 22.682

7.  Measurement of bicarbonate output from the intact human oesophagus.

Authors:  C M Brown; C F Snowdon; B Slee; L N Sandle; W D Rees
Journal:  Gut       Date:  1993-07       Impact factor: 23.059

8.  Human esophageal secretion: mucosal response to luminal acid and pepsin.

Authors:  Z Namiot; J Sarosiek; R M Rourk; D P Hetzel; R W McCallum
Journal:  Gastroenterology       Date:  1994-04       Impact factor: 22.682

9.  Effect of topical oesophageal acidification on human salivary and oesophageal alkali secretion.

Authors:  C M Brown; C F Snowdon; B Slee; L N Sandle; W D Rees
Journal:  Gut       Date:  1995-05       Impact factor: 23.059

10.  Acid clearance and oesophageal sensitivity in patients with progressive systemic sclerosis.

Authors:  G Basilisco; R Barbera; M Molgora; M Vanoli; P Bianchi
Journal:  Gut       Date:  1993-11       Impact factor: 23.059

View more
  1 in total

1.  Esophageal disease in progressive systemic sclerosis.

Authors:  Ellen C Ebert
Journal:  Curr Treat Options Gastroenterol       Date:  2008-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.